Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | EP300 | Q09472 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 3/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
| ▸ | TERT | O14746 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | BLM | P54132 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | FABP4 | P15090 | 2/20 | 0.40 |
| ▸ | GMNN | O75496 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL267255 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| SCHEMBL12335953 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| SCHEMBL7596228 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| SCHEMBL10496307 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| SCHEMBL10496303 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| SCHEMBL1921557 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| SCHEMBL265368 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 | |
| Heptanal Oxime SCHEMBL15257172 | 1.00 | — | — | |
| Heptanal Oxime SCHEMBL265491 | 1.00 | — | — | |
| SCHEMBL265367 | 1.00 | TSHR (0.52) | TSHRTHRBEP300FAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023213381-A1 | NOVEL FRAGRANCE COMPOUNDS | SYMRISE AG (DE) | 2023-11-09 | — | — | WO | claimed |
| EP-3723709-A1 | PERFUME MIXTURES CONTAINING 8,8-DIMETHYL-6,10-DIOXASPIRO[4,5]DECANE | Symrise AG (DE) | 2020-10-21 | — | — | EP | claimed |
| US-4528167-A | Selective solvent extraction using organophosphorus and carboxylic acids and a non-chelating aldehyde oxime | COUNCIL FOR MINERAL TECHNOLOGY (ZA) | 1985-07-09 | — | — | US | claimed |
| EP-4695016-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2026-02-18 | — | — | EP | disclosed |
| WO-2024213507-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-10-17 | — | — | WO | disclosed |
| US-12076436-B2 | Bacterial ferment of Lactobacillus species | SYMRISE AG (DE) | 2024-09-03 | — | — | US | disclosed |
| WO-2023213381-A1 | NOVEL FRAGRANCE COMPOUNDS | SYMRISE AG (DE) | 2023-11-09 | — | — | WO | disclosed |
| US-11753385-B2 | Method for producing kakeromycin and derivatives thereof | OP BIO FACTORY CO., LTD. (JP) | 2023-09-12 | — | — | US | disclosed |
| US-11753385-B2 | Method for producing kakeromycin and derivatives thereof | OP BIO FACTORY CO., LTD. (JP) | 2023-09-12 | — | — | US | disclosed |
| CN-115867541-A | Aminopyrimidinone derivatives | 豪夫迈·罗氏有限公司 | 2023-03-28 | — | — | CN | disclosed |
| US-20220354775-A1 | NOVEL BACTERIAL FERMENT OF LACTOBACILLUS SPECIES | SYMRISE AG (DE) | 2022-11-10 | — | — | US | disclosed |
| US-20180037555-A1 | METHOD FOR PRODUCING KAKEROMYCIN AND DERIVATIVES THEREOF | OP BIO FACTORY CO., LTD. (JP) | 2018-02-08 | — | — | US | disclosed |
| WO-2017070131-A2 | PARTICLES FOR MALODOR REDUCTION | THE PROCTER & GAMBLE COMPANY (US) | 2017-04-27 | — | — | WO | disclosed |
| EP-3131921-A1 | POLYPEPTIDES WITH LIPASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME | Novozymes A/S (DK) | 2017-02-22 | — | — | EP | disclosed |
| EP-3117001-A1 | POLYPEPTIDES WITH LIPASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME | Novazymes A/S (DK) | 2017-01-18 | — | — | EP | disclosed |
| WO-2015158237-A1 | POLYPEPTIDES WITH LIPASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME | NOVOZYMES A/S (DK) | 2015-10-22 | — | — | WO | disclosed |
| WO-2015135464-A1 | POLYPEPTIDES WITH LIPASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME | NOVOZYMES A/S (DK) | 2015-09-17 | — | — | WO | disclosed |
| US-7405318-B2 | Method for producing nitriles by elimination of water from aldehyde oximes with alkylphosphonic anhydrides | ARCHIMICA GMBH (DE) | 2008-07-29 | — | — | US | disclosed |
| US-20080033186-A1 | Method For Producing Nitriles By Elimination Of Water From Aldehyde Oximes With Alkylphosphonic Anhydrides | EUTICALS GMBH (DE) | 2008-02-07 | — | — | US | disclosed |
| US-4528167-A | Selective solvent extraction using organophosphorus and carboxylic acids and a non-chelating aldehyde oxime | COUNCIL FOR MINERAL TECHNOLOGY (ZA) | 1985-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180037555-A1 | METHOD FOR PRODUCING KAKEROMYCIN AND DERIVATIVES THEREOF | ERG28, CYP51A1, NISCH | TSHR 3590/4885THRB 3888/4885EP300 2899/4885 |
| US-11753385-B2 | Method for producing kakeromycin and derivatives thereof | ERG28, CYP51A1, NISCH | TSHR 3590/4885THRB 3888/4885EP300 2899/4885 |
| US-20080033186-A1 | Method For Producing Nitriles By Elimination Of Water From Aldehyde Oximes With Alkylphosphonic Anhydrides | NOX3, CA13, NOS3 | TSHR 754/4885THRB 1812/4885EP300 1002/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.